Oral Kohki Tea and its protective effect against in vitro ischemic damage to the bladder

Neurourology and Urodynamics

Volumn 23, Issue 4, 2004, Pages 355-360

  Levin, Robert M ^a,b   Leggett, Robert E ^a   Whitbeck, Catherine ^a   Murakami, Toshiyuki ^c   Kambara, Toshimitsu ^c   Aikawa, Ken ^d  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

^c Maruzen Pharmaceuticals Co Ltd   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bladder; BPH; Kohkitea; Obstruction

Indexed keywords

CARBACHOL; CARBON DIOXIDE; ENGELHARDTIA CHRYSOLEPSIS EXTRACT; FREE RADICAL; HERBACEOUS AGENT; NITROGEN; OXYGEN; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEVERAGE; BLADDER DISEASE; BLADDER ISCHEMIA; BLADDER NECK STENOSIS; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; ENGELHARDTIA CHRYSOLEPSIS; IN VITRO STUDY; ISCHEMIA; KOHKI TEA; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; RABBIT; TEA; TISSUE OXYGENATION;

ADMINISTRATION, ORAL; ANIMALS; ANOXIA; CARBACHOL; ELECTRIC STIMULATION; ISCHEMIA; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; POTASSIUM CHLORIDE; RABBITS; TEA; URINARY BLADDER;

EID: 3042800926     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.20033     Document Type: Article

References (40)

1. Azadzoi KM, Pontari M, Vlachiotis J, et al. 1996. Canine bladder blood flow and oxygenation: Changes induced by filling, contraction and outlet obstruction. J Urol 155:1459-65.
2. Breza J, Dzurny O, Borowka A, et al. 1998. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in central Europe. Curr Med Res Opin 14:127-39.
3. Buck AC. 1996. Phytotherapy for the prostate. Br J Urol 78:325-36.
4. Buttyan R, Chen M-W, Levin RM. 1997. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. Eur Urol 32(Suppl):32-9.
5. Carraro JC, Raynaud JP, Koch G, et al. 1996. Comparison of phytotherapy (Permixon) with finasteride in their treatment of benign prostatic hyperplasia: A randomized international study of 1098 patients. The Prostate 29:231-40.
6. Dreikorn K, Borkowski J, Braeckman J, et al. 1998. Other medical therapies. In: Denis L, Griffiths K, Khoury S, Cockett ATK, McConnell J, Chatelain C, Murphy G, Yoshida O, editors. Procedings from the 4th International Consultation on Benign Prostatic Hyperplasia. Paris, France: Scientific Communications, International, Ltd. pp 635-59.
7. Fitspatrick JM, Braeckman J, Denis L, et al. 1996. The medical management of BPH with agents other than hormones or alpha-blochers. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G, editors. Procedings from the 3rd International Consultation on Benign Prostatic Hyperplasia. Monaco: Scientific Communications, International, Ltd. pp 489-94.
8. Ghafar MA, Shabsigh A, Chichester P, et al. 2002. Effects of chronic partial outlet obstruction on blood flow and oxygenation of the rat bladder. J Urol 167:1508-12.
9. Gosling JA, Kung LS, Dixon JS, et al. 2000. Correlation between the structure and function of the urinary bladder following partial outlet obstruction. J Urol 163:1349-56.
10. Greenland JE, Hvistendahl JJ, Andersen H, et al. 1997. Detrusor and kidney blood flow is reduced in response to early bladder outlet obstruction in pigs. J Urol 157:172.
11. Greenland JE, Hvistendahl JJ, Andersen H, et al. 2000. The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder. B J U Int 85:1109-14.
12. Haraguchi H, Hashimoto K, Yagi A. 1992. Antioxidative substances in leaves of Polygonum Hudopiper. J Agric Food Chem 40:1349-51.
13. Haraguchi H, Mochida Y, Sakai S, et al. 1996a. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis. Biosci Biotechnol Biochem 60:945-8.
14. Haraguchi H, Ohmi I, Masuda H, et al. 1996b. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia 52:564-7.
15. Haraguchi H, Ohmi I, Fukuda A, et al. 1997. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci Biotechnol Biochem 61:651-54.
16. Hass MA, Levin RM. 2003. The role of lipids and lipid metabolites in urinary bladder dysfunction induced by partial outlet obstruction. Bladder Disease: Research Concepts and Applications. In: Anthony Atala and Debra Slade, editors. Advances in Experimental Medicine and Biology, Kluwer Academic/Plenum Publishers, NY. pp 217-38.
17. Hass MA, Leonova E, Levin RM. 1999. Fatty acid profiles in normal and obstructed rabbit bladder smooth muscle and mucosa. Neurourol Urodyn 18:697-711.
18. Igarashi K, Uchida Y, Murakami N, et al. 1996. Effect of astilbin in tea processed from leaves of Engelhardtia chrysolepis on the serum and liver lipid concentrations and on the erythrocyte and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem 60:513-5.
19. Levin RM, Das AK. 2000. A scientific basis for the therapeutic effects of Pygium africanum and Serenoa repens. Urol Res 28:201-9.
20. Levin RM, Longhurst PA, Monson FC, et al. 1990. Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladder. Prostate Suppl 3:9.
21. Levin RM, Monson FC, Longhurst PA, et al. 1994. The rabbit as a model of urinary bladder function. Neurourol Urodyn 13:119-36.
22. Levin RM, Monson FC, Haugaard N, et al. 1995. Genetic and cellular characteristics of bladder outlet obstruction. Urol Clin North Am 22:263-83.
23. Levin RM, Riffaud J-P, Bellamy F, et al. 1996. Effects of Tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstruction. J Urol 156:2084-8.
24. Levin RM, Das AK, Haugaard N, et al. 1997a. Beneficial effects of Tadenan therapy following two weeks of partial outlet obstruction in the rabbit. Neurourol Urodyn 16:583-99.
25. Levin RM, Levin SS, Zhao Y, et al. 1997b. Cellular and molecular aspects of bladder hypertrophy. Eur Urol 32(Suppl):15-21.
26. Levin RM, Whitbeck C, Horan P. 1998. Effect of calcium and calcium chelators on the response of the bladder to in vitro ischemia. Br J Urol 82:882-7.
27. Levin RM, Whitbeck C, Horan P. 1999. Correlation of EGTA and calcium blocking agents on the response of the bladder to in vitro ischemia. Pharmacology 58:113-9.
28. Levin RM, Haugaard N, O'Connor L, et al. 2000. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: A direct comparison. Neurourol Urodyn 19:609-29.
29. Levin RM, Leggett RE, Whitbeck C, et al. Kohki Tea protects the rabbit bladder from bilateral ischemia/reperfusion-induced contractile dysfunction. J Urol (in press).
30. Levin RM, Kawashima Y, Leggett RE, et al. 2002. Effect of oral Kohki tea on bladder dysfunction induced by severe partial outlet obstruction. J Urol 167:2260-6.
31. Levin RM, O'Connor LJ, Leggett RE, et al. 2003. Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation. Neurourol Urodyn 22:156-63.
32. Lin AT, Chen MT, Yang CH, et al. 1995a. Blood flow of the urinary bladder: Effects of outlet obstruction and correlation with bioenergetic metabolism. Neurourol Urodyn 14:285-92.
33. Lin AT-L, Yang CH, Chang LS. 1995b. Oxygen free radical-induced lipid peroxidation in overdistention of the rabbit urinary bladders. Neurourol Urodyn 14:553-4.
34. Lin AT-L, Yang CH, Chen KK, et al. 1996. Correlation of lipid peroxidation with energetic metabolism and contractile function in overdistention of the rabbit urinary bladder. Neurourol Urodyn 15:426-8.
35. Lowe FC, Dreikorn K, Borkowski A, et al. 1998. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH. Prostate 37:187-93.
36. Motoyashiki T, Miyake M, Morita T, et al. 1998. Enhancement of the vanadate-stimulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis. Biol Pharm Bull 21:517-9.
37. O'Connor LJ, Goldner CW, Lau ST, et al. 1999. The effect of partial outlet obstruction on the distribution of free fatty acids and phospholipids. World J Urol 17:261-5.
38. Ohnishi N, Liu S-P, Horan P, et al. 1998. Effect of repetitive stimulation on the contractile response of rabbit urinary bladder subjected to in vitro hypoxia or in vitro ischemia followed by reoxygenation. Pharmacology 57:139-47.
39. Schröder A, Chichester P, Kogan BA, et al. 2001. Effect of chronic bladder outlet obstruction on the blood flow of the rabbit urinary bladder. J Urol 165:640-6.
40. Zhao Y, Levin SS, Wein AJ, et al. 1997. Correlation of ischemia/reperfusion and partial outlet obstruction induced spectrin proteolysis by calpain with contractile dysfunction in the rabbit bladder. Urology 49:293-300.